Cargando…
Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: Evidence from a regression discontinuity design
BACKGROUND: In clinical trials, several SARS-CoV-2 vaccines were shown to reduce risk of severe COVID-19 illness. Local, population-level, real-world evidence of vaccine effectiveness is accumulating. We assessed vaccine effectiveness for community-dwelling New York City (NYC) residents using a quas...
Autores principales: | Greene, Sharon K., Levin-Rector, Alison, McGibbon, Emily, Baumgartner, Jennifer, Devinney, Katelynn, Ternier, Alexandra, Sell, Jessica, Kahn, Rebecca, Kishore, Nishant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694652/ https://www.ncbi.nlm.nih.gov/pubmed/34961848 http://dx.doi.org/10.1016/j.jvacx.2021.100134 |
Ejemplares similares
-
Effects of Return-to-Office, Public Schools Reopening, and Vaccination Mandates on COVID-19 Cases Among Municipal Employee Residents of New York City
por: Greene, Sharon K., et al.
Publicado: (2023) -
Built by epidemiologists for epidemiologists: an internal COVID-19 dashboard for real-time situational awareness in New York City
por: Ngai, Stephanie, et al.
Publicado: (2022) -
Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021
por: Levin-Rector, Alison, et al.
Publicado: (2022) -
Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant — New York City, New York, January 1–April 5, 2021
por: Thompson, Corinne N., et al.
Publicado: (2021) -
Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022
por: Greene, Sharon K., et al.
Publicado: (2022)